Effects of mandibular advancement devices on the evolution of obstructive sleep apnea.

Abstract

Mandibular advancement devices (MADs) are a treatment for obstructive sleep apnea (OSA). Titration is a necessary component of proper fitting of MADs, yet little is known about what happens at each step of the titration. The objectives of this study were to determine the clinical and paraclinical evolution of OSA at every mm of MAD advancement. Volunteers were fitted with MADs set to 50% of maximum advancement. MAD clinical and paraclinical results were recorded at every additional mm-titration, including apnea-hypopnea index (AHI), as well as symptoms of sleepiness and fatigue. In 20 volunteers with OSA, the MAD had a significant effect on every polygraphic parameter at the onsetof use. The mean AHI with MAD fell by 15.2/h (p < 0.001). The mean Epworth Sleepiness Score and Pichot Fatigue questionnaire with MAD fell by 2.0 (p = 0.0687) and 2.4 (p = 0.1073)respectively. There was no proportionality between clinical gains (drowsiness and fatigue) and AHI improvements. MADs led to a significant improvement inAHI and other polygraphic parameters from the onsetof use. The decrease of clinical symptoms (drowsiness and fatigue) was more complex to interpret because of the small decreasesobserved. The absence of concordance between AHI improvement and clinical symptoms was nevertheless objectively quantified and symptoms were alleviated with advancements. The findings suggest that it may be appropriate to use clinical symptoms as a main aim of titration, sincethe improvement in AHI is reached at the onsetof MAD use.